The role of 5α‐reductase inhibitors in gastro‐oesophageal cancer risk : A nested case‐control study
| dc.contributor.author | Busby, John | |
| dc.contributor.author | Karasneh, Reema | |
| dc.contributor.author | Murchie, Peter | |
| dc.contributor.author | McMenamin, Úna | |
| dc.contributor.author | Gadalla, Shahinaz M. | |
| dc.contributor.author | Camargo, M. Constanza | |
| dc.contributor.author | Iversen, Lisa | |
| dc.contributor.author | Lee, Amanda J. | |
| dc.contributor.author | Spence, Andrew D. | |
| dc.contributor.author | Cardwell, Chris R. | |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Medical Statistics | en |
| dc.date.accessioned | 2020-11-12T00:07:15Z | |
| dc.date.available | 2020-11-12T00:07:15Z | |
| dc.date.embargoedUntil | 2020-11-12 | |
| dc.date.issued | 2020-01 | |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 9 | |
| dc.format.extent | 358678 | |
| dc.identifier | 147682256 | |
| dc.identifier | dcf1515b-9b33-4521-909f-cdcedc11be11 | |
| dc.identifier | 000495812700001 | |
| dc.identifier | 31713940 | |
| dc.identifier | 85075021588 | |
| dc.identifier.citation | Busby, J, Karasneh, R, Murchie, P, McMenamin, Ú, Gadalla, S M, Camargo, M C, Iversen, L, Lee, A J, Spence, A D & Cardwell, C R 2020, 'The role of 5α‐reductase inhibitors in gastro‐oesophageal cancer risk : A nested case‐control study', Pharmacoepidemiology and Drug Safety, vol. 29, no. 1, pp. 48-56. https://doi.org/10.1002/pds.4909 | en |
| dc.identifier.doi | 10.1002/pds.4909 | |
| dc.identifier.iss | 1 | en |
| dc.identifier.issn | 1053-8569 | |
| dc.identifier.other | ORCID: /0000-0001-9968-5991/work/83704212 | |
| dc.identifier.other | ORCID: /0000-0002-4865-9061/work/159078259 | |
| dc.identifier.uri | https://hdl.handle.net/2164/15355 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85075021588&partnerID=8YFLogxK | en |
| dc.identifier.vol | 29 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Pharmacoepidemiology and Drug Safety | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | gastric cancer | en |
| dc.subject | oesophageal cancer | en |
| dc.subject | Androgen | en |
| dc.subject | 5α-reductase inhibitor | en |
| dc.subject | ANDROGEN RECEPTOR | en |
| dc.subject | androgen | en |
| dc.subject | ADENOCARCINOMA | en |
| dc.subject | FINASTERIDE | en |
| dc.subject | BARRETTS-ESOPHAGUS | en |
| dc.subject | 5 alpha-reductase inhibitor | en |
| dc.subject | SEX-HORMONE RECEPTORS | en |
| dc.subject | GASTRIC-CANCER | en |
| dc.subject | CELL-MIGRATION | en |
| dc.subject | PROSTATE-CANCER | en |
| dc.subject | ESOPHAGEAL CANCER | en |
| dc.subject | EXPRESSION | en |
| dc.subject | RC0254 Neoplasms. Tumors. Oncology (including Cancer) | en |
| dc.subject | Pharmacology (medical) | en |
| dc.subject | Epidemiology | en |
| dc.subject | Supplementary Data | en |
| dc.subject.lcc | RC0254 | en |
| dc.title | The role of 5α‐reductase inhibitors in gastro‐oesophageal cancer risk : A nested case‐control study | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Busby_et_al_5ar_go_05_08_19_AAM.pdf
- Size:
- 350.27 KB
- Format:
- Adobe Portable Document Format
